Board Certifications – Certified Family Nurse Practitioner (ANCC)
Specialties & Main Areas of Interest
Liver Disease
Irritable Bowel Syndrome (IBS)
Inflammatory Bowel Disease (IBD)
Biologic infusions for Inflammatory Bowel Disease
Hospital Affiliations
Good Samaritan
Montefiore Nyack Hospital
Research
A Long Term Safety Study of Zileuton Controlled-Release plus Usual Care Versus Placebo
plus Usual Care in Patients with Asthma (Phase III, 1997)
Effect of Ragweed Allergy and the Treatment of Allergy Symptoms with Fexofenadine HCL, or Clemastine on Scholastic Aptitude Test (SAT)
A Long Term Safety Study of Azmacort HFA-134a and Azmacort Forte HFA-134a Oral Inhaler the Treatment of Adults Asthmatics. (Phase III Study, 1996)
2000 – A Twelve Week Randomized Double Blind, Placebo Controlled Study of the Efficacy and Tolerability of Alosetron Hydrochloride 1 mg. Twice Daily For The Control Of Bowel Urge In Females With Non-Constipated IBS in an Independent Pracitioner Association Model:
Protocol #S3B4005 l
2000- START: Standard Therapeutic Assessment of Rebetron Trial.
Indiana University, Indiana
Are you finding it challenging to lose weight despite your efforts with diet and exercise?
We understand the complexities of weight loss. That’s why we’re excited to announce our new partnership with KORB Health to offer a medical weight loss program that includes the medication Semaglutide (same active ingredient as Ozempic).